CAHP Statement: PhRMA SB 17 Litigation
As part of its usual obstructionist playbook, the Pharmaceutical Research and Manufacturers of America (PhRMA) today filed a lawsuit challenging California’s recently-passed drug pricing transparency law, SB 17.
CAHP Fact Sheet: New Health Care Mandates Would Drive Up Premiums By $943 Million
CAHP Fact Sheet: Say No to SB 598: A Prescription for Low-Value Healthcare